The central hypothesis posits that if a deranged ICP control is the shared pathogenetic step between migraine and IIHWOP, responsible for their striking clinical and pathogenetic similarities, then GLP‐1R agonists should improve migraine frequency and intensity. This evidence concerns the gene GLP1R and migraine disorder.